Mylan And Biocon Launch Fulphila In Canada

Biosimilar Pegfilgrastim Rival To Neulasta Joins Apotex’ Lapelga Version

 
• By Dave Wallace

Mylan and Biocon have introduced the second biosimilar pegfilgrastim rival to Neulasta in Canada with the launch of their Fulphila version.

Canada_Victory_Sign
Mylan and Biocon’s Fulphila is the second biosimilar pegfilgrastim in Canada • Source: Shutterstock

More from Products

More from Generics Bulletin